Calcitriol Attenuates Doxorubicin-Induced Cardiac Dysfunction and Inhibits Endothelial-to-Mesenchymal Transition in Mice

Doxorubicin (Dox) is an effective anti-neoplasm drug, but its cardiac toxicity limits its clinical use. Endothelial-to-mesenchymal transition (EndMT) has been found to be involved in the process of heart failure. It is unclear whether EndMT contributes to Dox-induced cardiomyopathy (DoIC). Calcitrio...

Full description

Bibliographic Details

Published in:	Cells
Main Authors:	Tzu-Hsien Tsai, Cheng-Jei Lin, Chi-Ling Hang, Wei-Yu Chen
Format:	Article
Language:	English
Published:	MDPI AG 2019-08-01
Subjects:	endothelial-to-mesenchymal transition doxorubin cardiac fibrosis calcitriol
Online Access:	https://www.mdpi.com/2073-4409/8/8/865